Development & demonstration of low environmental impact innovation and optimization practices in pharma production

LIFE-GREENAPI aims to revolutionize API production in Europe by implementing flow-chemistry to enhance sustainability, reduce environmental impact, and support the pharmaceutical sector's decarbonization efforts.

Subsidie
€ 1.516.536
2023

Projectdetails

Introduction

LIFE-GREENAPI aims at proposing a technological shift in Active Pharmaceutical Ingredients (APIs) production, enabling sustainability of the European Pharmaceutical Sector, which is recognized as being one of the most difficult sectors to decarbonize, given the stringent regulatory limits.

Collaboration and Development

Angelini Pharma, in collaboration with the University of Leiden, will engineer, test, scale-up, and demonstrate at an industrial level the environmental benefit of an innovative approach for the manufacturing of APIs, switching from batch to flow-chemistry.

Implementation Strategy

The technological innovation will be first developed and tested on a selected high-production volume API (400 t/y in Europe), and then replicated on two additional small molecules, in order to demonstrate the broad spectrum of applicability.

Expected Environmental Impacts

The novel approach is expected to lead to important environmental impacts:

  • Reduction in use of dangerous chemicals: 6.5 tons initially, expected to become more than 473 tons/y after 5 years of replication.
  • Energy consumption reduction: 33%, corresponding to 5 MWh saved in the 3-year project and 360 MWh/y after 5 years from the project end.
  • Reduction of inappropriately managed waste: More than 10 tons, leading to 714 tons/y after 5 years.
  • Reduction of water usage: More than 880 m³, equating to 64,192 m³/y after 5 years.
  • CO2eq overall reduction: Equal to 31 tCO2eq within the project duration and 2,230 tCO2eq/y after 5 years.

Market Impact and Stakeholder Involvement

LIFE-GREENAPI is bringing to the EU market a concrete way to support pharma industries in their journey towards net-zero emissions: a very difficult goal for such a strictly regulated sector.

Future Adoption

LIFE-GREENAPI will involve several stakeholders from the Pharma business in Europe and will pave the way for the broad adoption of the flow-chemistry technology in APIs manufacturing. It will demonstrate the real savings, both from environmental and economic perspectives, through a full Life Cycle Assessment (LCA) and risk assessment that will be performed on the whole production process.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.516.536
Totale projectbegroting€ 2.527.561

Tijdlijn

Startdatum1-6-2023
Einddatum31-5-2026
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO - A.C.R.A.F. - SPApenvoerder
  • UNIVERSITEIT LEIDEN

Land(en)

ItalyNetherlands

Vergelijkbare projecten binnen LIFE

LIFE CET

Integrated Quality Services for Home Renovation Roadmap

EASIER enhances energy renovation for condominiums in Italy by integrating public-private services, training stakeholders, and utilizing digital tools to simplify processes and promote energy savings.

€ 1.046.588
LIFE CET

Bringing local and regional municipalities towards owning their SECAPs

OwnYourSECAP aims to empower over 110 municipalities to develop and implement effective climate action plans through systematic energy management, adaptation strategies, and stakeholder engagement.

€ 1.722.726
LIFE CET

Improving and demonstrating the potential of SRI

easySRI develops a web platform for automated Smart Readiness Indicator calculations, enhancing energy efficiency insights and supporting ML-based evaluations for building upgrades and stakeholder engagement.

€ 1.999.334
LIFE CET

Decentralization, Diversity and Dynamic load regulation – novel approaches to tangible energy transition with diversification of production sources

3DIVERSE aims to integrate sustainable energy investments through a coordinated multi-sector approach, enhancing citizen engagement and financing to create a replicable model for energy transition.

€ 1.377.987

Vergelijkbare projecten uit andere regelingen

ERC POC

Metaraminol Demonstration Plant as Commercialisation Blueprint for Sustainable Production of Pharmaceuticals using Enzyme Cascades

'SusECAS - DemoPlant' aims to establish a sustainable, biocatalytic process for producing amino alcohols in Europe, enhancing ecological and economic viability while facilitating market entry.

€ 150.000
EIC Pathfinder

Fibre-based plasmonic micro reactor for flow chemistry

The project aims to develop a novel light-driven chemical reactor using advanced technologies to enable sustainable production of chemicals, supporting the EU's goal of climate neutrality by 2050.

€ 3.111.973
EIC Accelerator

AlkaBurst2.0 – A game changing bioreactor for sustainable production of active pharmaceutical ingredients in a consistent, traceable and low cost approach

Alkion is developing a sustainable biorefinery using its AlkaBurst2.0 technology to produce high-quality APIs locally, aiming for significant cost savings and revenue growth by 2028.

€ 2.500.000
MIT Haalbaarheid

Gewassen voor winning van bio-based APIs

Perfect Plants onderzoekt kweek- en oogsttechnieken voor GMP-certificering om natuurlijke actieve ingrediënten uit plantaardige restromen te integreren in de farmaceutische industrie.

€ 20.000